196 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
planning. Moreover, the Compensation Committee is responsible for reviewing and making recommendations to the Board as to the compensation … before such disclosure is submitted to the Board for approval. The Nominating and Corporate Governance Committee is also responsible for the review
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
will be responsible.
Indemnification of Officers and Directors
All rights to indemnification, advancement of expenses, and exculpation by the Company existing
6-K
EX-99.3
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
are responsible for the proper completion of this Letter of Transmittal;
acknowledges that the delivery of the Deposited Shares shall be effected … and successors, are responsible for such currency exchange risk.
By reason of the use by the undersigned of an English language form of Letter
6-K
EX-99.4
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those
6-K
EX-99.3
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting
6-K
EX-99.2
wn8axo7u hwp
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.2
i87eas9yobv4
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
q5o4o9gs2zm i1
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.4
moyuyc7o36 484
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
6-K
EX-99.3
tfyguevm3my h5b1fw
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
scv a39wttn4tx2jt47
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
4mgon855f0kb0l 7t2
14 Nov 22
Open Market Sale Agreementsm
5:19pm
6-K
EX-99.1
xptjp3dplcc0xe
16 Sep 22
Investor Presentation NASDAQ/TSX - BLU September 16 th , 2022
4:40pm
F-10
uhrqu6q0vi3
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.3
320609
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.4
fdj6l9
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
SUPPL
ckl0n 2c35fwnhq3ya
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
3bw551u7
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
piajwh1qdhhea0ufh mc
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.4
jedf4
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm